The Anondita Medicare IPO is set to open on August 22, 2025, and will close on August 26, 2025. This IPO is a Book Built Issue, with the company aiming to raise approximately ₹69.50 crores through a fresh issue of ₹69.50 crores and an offer for sale of up to [.] equity shares, each with a face value of ₹10.
The price band for the Anondita Medicare IPO is between ₹137 and ₹145 per share. The allocation for retail investors is 35%, while Qualified Institutional Buyers (QIB) will receive 50%, and High Net-worth Individuals (HNI) will get 15%. The listing of the Anondita Medicare IPO on the NSE SME is scheduled for September 1, 2025, with the allotment date set for August 28, 2025.
In terms of financial performance, the company reported a revenue of ₹77.13 crores in 2025, compared to ₹46.56 crores in 2024. Additionally, the profit for 2025 was ₹16.42 crores, a significant increase from ₹3.84 crores in 2024. Based on these financials, it is advisable for IPO investors to consider applying for the IPO with a long-term perspective.
Anondita Medicare IPO Details
| IPO Open Date: | August 22, 2025 |
| IPO Close Date: | August 26, 2025 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹137 to ₹145 Per Share |
| Issue Size: | Approx ₹69.50 Crores |
| Fresh Issue: | Approx ₹69.50 Crores |
| Lot Size: | 1,000 Shares |
| Issue Type: | Book Built Issue |
| IPO Listing: | NSE SME |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
Anondita Medicare IPO Market Lot
The Anondita Medicare IPO minimum market lot is 2,000 shares with ₹2,90,000 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 2,000 | ₹2,90,000 |
| Retail Maximum | 2 | 2,000 | ₹2,90,000 |
| S-HNI Minimum | 3 | 3,000 | ₹4,35,000 |
| B-HNI Minimum | 7 | 7,000 | ₹10,15,000 |
Anondita Medicare IPO Dates
The Anondita Medicare IPO date is August 22 and the close date is August 26. The Anondita Medicare IPO allotment will be finalized on August 28 and the IPO listing on September 1.
| IPO Open Date: | August 22, 2025 |
| IPO Close Date: | August 26, 2025 |
| Basis of Allotment: | August 28, 2025 |
| Refunds: | August 29, 2025 |
| Credit to Demat Account: | August 29, 2025 |
| IPO Listing Date: | September 1, 2025 |
Anondita Medicare IPO Company Financial Report
The company reported revenue of ₹77.13 crores in 2025 against ₹46.56 crores in 2024. The company reported profit of ₹16.42 crores in 2025 against profit of ₹3.84 crores in 2024.
Amount ₹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
| 2023 | ₹36.14 | ₹35.67 | ₹0.35 | ₹37.80 |
| 2024 | ₹46.56 | ₹41.40 | ₹3.84 | ₹42.92 |
| 2025 | ₹77.13 | ₹55.18 | ₹16.42 | ₹78.27 |
Anondita Medicare IPO Valuation – FY2025
Check Anondita Medicare IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 41.71% |
| ROCE: | 37.42% |
| EBITDA Margin: | 33.32% |
| PAT Margin: | 21.32% |
| Debt to equity ratio: | 0.97 |
| Earning Per Share (EPS): | ₹9.60 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 38.10% |
| Net Asset Value (NAV): | ₹21.32 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Cupid Limited | 1.52 | 110.38 | 11.96 | 12.75 | 40.93 Cr. |
Objects of the Issue
- Funding capital expenditure requirements for the purchase of equipment/machineries
- Funding the Working Capital requirement
- Unidentified Acquisition and General Corporate Purposes
About Anondita Medicare IPO
Anondita Medicare Limited, established in March 2024, is a rapidly growing company that specializes in the production of flavored male condoms under its flagship brand, "COBRA." The firm boasts an impressive annual output of 562 million condoms. Its manufacturing facilities are located in Noida, Uttar Pradesh. Anondita Medicare exports its products to regions including Southeast Asia, Africa, and the Middle East. The company collaborates with global health organizations, NGOs, and government entities to advance family planning and public health initiatives. Additionally, Anondita Medicare Limited has developed a robust distribution network that ensures timely delivery of its products to various markets.
Anondita Medicare works alongside wholesalers, retailers, and e-commerce platforms to ensure that its products are readily accessible to all. As of July 31, 2025, the company employs 280 individuals. Furthermore, it collaborates with government health programs to provide essential medical supplies.